CD19 and atherosclerosis: Also, the negative correlation of −0.43 between CD19+ cell levels and coronary heart disease (CHD) may be related to the fact that B-lymphocytes have a modulating effect on inflammation, which plays a central role in the pathogenesis of atherosclerosis, the main mechanism of CHD development.